05/28/2026
Imagine a future where medicine can be delivered directly to the brain to treat Alzheimer’s, dementia and brain injuries. 🧠 That’s exactly what researchers at Texas A&M are working on.
Dr. Peter Davies from Texas A&M Institute of Biosciences and Technology (IBT), Dr. Wenshe Liu from Texas A&M Chemistry and Dr. Vicente Rubio—an IBT post-doctoral fellow—are using a mix of artificial intelligence and chemistry to design special synthetic peptides that transport therapeutics across the blood-brain barrier to treat conditions in the brain.
This cutting-edge work is supported by a Texas A&M Health Dementia and Alzheimer’s Research Initiative seedling grant and could bring new hope for early intervention in neurodegenerative diseases.
Read more about their research:
FacebookTweet What if the body had a shuttle service to deliver medication directly to the brain? One research team believes they might have a way to make it a reality. Peter Davies, MD, PhD, deputy director at the Texas A&M Health Institute of Biosciences and Technology, and his colleagues have bee...